NYSE:OLN - Olin Stock Price, News, & Analysis

Olin trades on the New York Stock Exchange (NYSE) under the ticker symbol "OLN."

Olin announced a quarterly dividend on Friday, January 25th. Investors of record on Monday, February 11th will be given a dividend of $0.20 per share on Monday, March 11th. This represents a $0.80 annualized dividend and a yield of 3.55%. The ex-dividend date of this dividend is Friday, February 8th. View Olin's Dividend History.

Olin announced that its board has initiated a stock repurchase program on Tuesday, May 1st 2018, which permits the company to repurchase $500,000,000.00 in shares, according to EventVestor. This repurchase authorization permits the company to repurchase up to 9.9% of its shares through open market purchases. Shares repurchase programs are usually an indication that the company's leadership believes its shares are undervalued.

Olin Co. (NYSE:OLN) announced its quarterly earnings data on Monday, February, 4th. The specialty chemicals company reported $0.32 earnings per share for the quarter, missing the Thomson Reuters' consensus estimate of $0.34 by $0.02. The specialty chemicals company earned $1.64 billion during the quarter, compared to analyst estimates of $1.70 billion. Olin had a return on equity of 10.42% and a net margin of 4.72%. The company's quarterly revenue was up .9% compared to the same quarter last year. During the same quarter last year, the business earned $2.89 earnings per share. View Olin's Earnings History.

Olin is scheduled to release their next quarterly earnings announcement on Tuesday, May 7th 2019. View Earnings Estimates for Olin.

11 brokers have issued 1 year price targets for Olin's shares. Their predictions range from $20.00 to $40.00. On average, they expect Olin's share price to reach $29.2727 in the next year. This suggests a possible upside of 29.9% from the stock's current price. View Analyst Price Targets for Olin.

11 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Olin in the last year. There are currently 1 sell rating, 3 hold ratings and 7 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Olin.

News headlines about OLN stock have been trending somewhat positive this week, InfoTrie Sentiment reports. The research firm identifies positive and negative news coverage by reviewing more than six thousand blog and news sources in real-time. The firm ranks coverage of companies on a scale of -5 to 5, with scores closest to five being the most favorable. Olin earned a news impact score of 0.9 on InfoTrie's scale. They also gave media stories about the specialty chemicals company a news buzz of 2.0 out of 10, indicating that recent news coverage is very unlikely to have an effect on the stock's share price in the immediate future.

Olin saw a increase in short interest during the month of February. As of February 15th, there was short interest totalling 7,278,381 shares, an increase of 81.8% from the January 31st total of 4,003,137 shares. Based on an average trading volume of 2,742,454 shares, the days-to-cover ratio is currently 2.7 days. Currently, 4.4% of the shares of the company are sold short. View Olin's Current Options Chain.

Some companies that are related to Olin include ASAHI KASEI COR/ADR (AHKSY), FMC (FMC), Johnson Matthey (JMPLY), Chemours (CC), W. R. Grace & Co (GRA), Huntsman (HUN), Ashland Global (ASH), KURARAY CO LTD/ADR (KURRY), Ingevity (NGVT), Univar (UNVR), Balchem (BCPC), GCP Applied Technologies (GCP), PQ Group (PQG), Innospec (IOSP) and KMG Chemicals (KMG).

Based on aggregate information from My MarketBeat watchlists, some companies that other Olin investors own include General Electric (GE), AT&T (T), Exxon Mobil (XOM), Verizon Communications (VZ), Altria Group (MO), PepsiCo (PEP), IBM (IBM), AbbVie (ABBV), Procter & Gamble (PG) and Cisco Systems (CSCO).

Olin's stock is owned by many different of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (11.60%), FMR LLC (7.42%), Dimensional Fund Advisors LP (3.20%), Macquarie Group Ltd. (2.42%), Millennium Management LLC (1.49%) and Bank of New York Mellon Corp (1.46%). Company insiders that own Olin stock include Brett A Flaugher, C Robert Bunch, Dolores J Ennico, Donald W Bogus, Earl L Shipp, John E Fischer, John L Mcintosh, John Maurice Sampson, Randall W Larrimore, Scott Mcdougald Sutton and Stephen C Curley. View Institutional Ownership Trends for Olin.

OLN stock was sold by a variety of institutional investors in the last quarter, including Millennium Management LLC, Prudential PLC, Squarepoint Ops LLC, Manning & Napier Group LLC, Quantum Capital Management, Boston Partners, SG Americas Securities LLC and American Century Companies Inc.. Company insiders that have sold Olin company stock in the last year include Brett A Flaugher and John L Mcintosh. View Insider Buying and Selling for Olin.

OLN stock was bought by a variety of institutional investors in the last quarter, including FMR LLC, Norges Bank, Oregon Public Employees Retirement Fund, Deprince Race & Zollo Inc., Beaconlight Capital LLC, Dimensional Fund Advisors LP, BlackRock Inc. and Bank of New York Mellon Corp. Company insiders that have bought Olin stock in the last two years include Donald W Bogus, Earl L Shipp, John Maurice Sampson, Randall W Larrimore and Scott Mcdougald Sutton. View Insider Buying and Selling for Olin.

Shares of OLN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of OLN stock can currently be purchased for approximately $22.53.

Olin has a market capitalization of $3.71 billion and generates $6.95 billion in revenue each year. The specialty chemicals company earns $327.90 million in net income (profit) each year or $1.75 on an earnings per share basis. Olin employs 6,500 workers across the globe.

The official website for Olin is http://www.olin.com.

Olin's mailing address is 190 CARONDELET PLAZA SUITE 1530, CLAYTON MO, 63105. The specialty chemicals company can be reached via phone at 314-480-1400 or via email at [email protected]